16 September 2019 - This study's intent was to determine if a qualitative benefit risk framework could be used or modified to further enable health technology reassessment of prescription medicine recommendations. 

The purpose of this research was to understand Canadian Health Technology Agency assessors past experiences and insights to inform any modifications to the Universal Methodology for Benefit−Risk Assessment (UMBRA) qualitative framework. 

The UMBRA framework consists of an eight-step process, used during the assessment phase, to aid in decision making and dissemination.

Read International Journal of Technology Assessment in Health Care article